医療者と患者の信頼関係を構築するコミュニケーション

AYA世代（思春期・若年成人）がん患者の支援の現状

腫瘍微小環境における免疫抑制機構の解明

前立腺がん治療におけるPSMA標的療法の台頭

非小細胞肺がん免疫療法の進展

がん緩和ケアの最前線と患者支援の具体例

番組リニューアルのお知らせ

Language Change Announcement – Japanese Only Going（番組リニューアルのお知らせとお詫び）

【日】Neoadjuvant Chemotherapy, Case Volume, and Mortality in Advanced Ovarian Cancer.

【英】Neoadjuvant Chemotherapy, Case Volume, and Mortality in Advanced Ovarian Cancer

【日】Structured Exercise after Adjuvant Chemotherapy for Colon Cancer.

【英】Structured Exercise after Adjuvant Chemotherapy for Colon Cancer

【日】Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer.

【英】Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

【日】Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer

【英】Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer

【日】Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.

【英】Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma

【日】Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer Survivors.

【英】Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer Survivors